DEARBORN PARTNERS LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEARBORN PARTNERS LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2015$588,000
-2.8%
13,095
-19.0%
0.05%
-8.9%
Q4 2014$605,000
+3.6%
16,165
-3.4%
0.06%
-1.8%
Q3 2014$584,000
+26.7%
16,735
+28.1%
0.06%
+26.7%
Q2 2014$461,000
+41.8%
13,065
+31.2%
0.04%
+28.6%
Q1 2014$325,000
-22.6%
9,9600.0%0.04%
-28.6%
Q4 2013$420,000
-0.2%
9,960
-5.7%
0.05%
-10.9%
Q3 2013$421,000
-3.7%
10,5600.0%0.06%
-11.3%
Q2 2013$437,00010,5600.06%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders